ArticleClinical and molecular hepatology2026

Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations.

Sherlot Juan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.